Renal Cancer
HDAC6 serves as a biomarker for the prognosis of patients with renal cell carcinoma
February 3, 2017
Influence of VEGFR single nucleotide polymorphisms on the efficacy of sunitinib therapy against renal cell carcinoma
February 2, 2017
Cytoreductive Surgery in the Management of Renal Tumours: Rationale, Current Evidence and Future Perspectives
January 31, 2017
Magnetic Resonance Imaging and the Use in Small Renal Masses
January 31, 2017
[What can/should be treated in kidney tumors and when]
January 30, 2017
Bullous Pemphigoid Associated with Nivolumab, a Programmed Cell Death 1 Protein Inhibitor
January 30, 2017
Validation of preoperative variables and stratification of patients to help predict benefit of cytoreductive nephrectomy in the targeted therapy ERA
January 30, 2017
Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection
January 27, 2017
Core Needle Biopsy and Fine Needle Aspiration Alone or in Combination: Diagnostic Accuracy and Impact on Management of Renal Masses
January 27, 2017
The next 10 years: Challenges for the future and overcoming resistance to targeted therapies for renal cell carcinoma
January 26, 2017
First-line treatment options in metastatic renal cell cancer
January 26, 2017
Sunitinib side effects as surrogate biomarkers of efficacy
January 26, 2017